The University of Chicago Header Logo

Connection

Mark W. Lingen to Loss of Heterozygosity

Back to Details
This is a "connection" page, showing publications Mark W. Lingen has written about Loss of Heterozygosity.
Mark W. Lingen
Connection Strength
0.526
Loss of Heterozygosity
  1. Validation of LOH profiles for assessing oral cancer risk. Cancer Prev Res (Phila). 2012 Sep; 5(9):1075-7.
    View in: PubMed
    Score: 0.432
  2. Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma. Oncotarget. 2017 Mar 21; 8(12):18726-18734.
    View in: PubMed
    Score: 0.037
  3. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. JAMA Oncol. 2016 Feb; 2(2):209-16.
    View in: PubMed
    Score: 0.034
  4. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. PLoS Comput Biol. 2010 Apr 01; 6(4):e1000730.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.